134 related articles for article (PubMed ID: 29754764)
1. Monitoring of early humoral immunity to identify lung recipients at risk for development of serious infections: A multicenter prospective study.
Sarmiento E; Cifrian J; Calahorra L; Bravo C; Lopez S; Laporta R; Ussetti P; Sole A; Morales C; de Pablos A; Jaramillo M; Ezzahouri I; García S; Navarro J; Lopez-Hoyos M; Carbone J
J Heart Lung Transplant; 2018 Aug; 37(8):1001-1012. PubMed ID: 29754764
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.
Sarmiento E; Jaramillo M; Calahorra L; Fernandez-Yañez J; Gomez-Sanchez M; Crespo-Leiro MG; Paniagua M; Almenar L; Cebrian M; Rabago G; Levy B; Segovia J; Gomez-Bueno M; Lopez J; Mirabet S; Navarro J; Rodriguez-Molina JJ; Fernandez-Cruz E; Carbone J
J Heart Lung Transplant; 2017 May; 36(5):529-539. PubMed ID: 27866926
[TBL] [Abstract][Full Text] [Related]
3. Secondary antibody deficiency is associated with development of infection in kidney transplantation: Results of a multicenter study.
Sarmiento E; Jimenez M; di Natale M; Rodriguez-Ferrero M; Anaya F; Lopez-Hoyos M; Rodrigo E; Arias M; Perello M; Seron D; Karanovic B; Ezzahouri I; Mezzano S; Jaramillo M; Calahorra L; Alarcon A; Navarro J; Muñoz P; Carbone J
Transpl Infect Dis; 2021 Apr; 23(2):e13494. PubMed ID: 33064917
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an immunological score to assess the risk of severe infection in heart recipients.
Sarmiento E; Navarro J; Fernandez-Yañez J; Palomo J; Muñoz P; Carbone J
Transpl Infect Dis; 2014 Oct; 16(5):802-12. PubMed ID: 25179534
[TBL] [Abstract][Full Text] [Related]
5. Hypogammaglobulinemia in lung transplant recipients.
Goldfarb NS; Avery RK; Goormastic M; Mehta AC; Schilz R; Smedira N; Pien L; Haug MT; Gordon SM; Hague LK; Dresing JM; Evans-Walker T; Maurer JR
Transplantation; 2001 Jan; 71(2):242-6. PubMed ID: 11213067
[TBL] [Abstract][Full Text] [Related]
6. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.
Santos CA; Brennan DC; Yusen RD; Olsen MA
Transplantation; 2015 Aug; 99(8):1658-66. PubMed ID: 25675196
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
[TBL] [Abstract][Full Text] [Related]
8. Soluble HLA-G pre-transplant levels to identify the risk for development of infection in heart transplant recipients.
Bortolotti D; Gentili V; Rotola A; Potena L; Rizzo R
Hum Immunol; 2020 Apr; 81(4):147-150. PubMed ID: 31677945
[TBL] [Abstract][Full Text] [Related]
9. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
10. CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients.
Schulz U; Solidoro P; Müller V; Szabo A; Gottlieb J; Wilkens H; Enseleit F
Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S5-10. PubMed ID: 26900992
[TBL] [Abstract][Full Text] [Related]
11. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
13. IgG monitoring to identify the risk for development of infection in heart transplant recipients.
Sarmiento E; Rodriguez-Molina JJ; Fernandez-Yañez J; Palomo J; Urrea R; Muñoz P; Bouza E; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2006 Mar; 8(1):49-53. PubMed ID: 16623821
[TBL] [Abstract][Full Text] [Related]
14. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
Avery RK; Silveira FP; Benedict K; Cleveland AA; Kauffman CA; Schuster MG; Dubberke ER; Husain S; Paterson DL; Chiller T; Pappas P
Transpl Infect Dis; 2018 Jun; 20(3):e12877. PubMed ID: 29512935
[TBL] [Abstract][Full Text] [Related]
16. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
Eichler C; Kaden J; May G
Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and risk factors for late infection in solid organ transplant recipients.
Cervera C; Fernández-Ruiz M; Valledor A; Linares L; Antón A; Ángeles Marcos M; Sanclemente G; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Pumarola T; Moreno A
Transpl Infect Dis; 2011 Dec; 13(6):598-607. PubMed ID: 21535336
[TBL] [Abstract][Full Text] [Related]
19. Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon?
Corales R; Chua J; Mawhorter S; Young JB; Starling R; Tomford JW; McCarthy P; Braun WE; Smedira N; Hobbs R; Haas G; Pelegrin D; Majercik M; Hoercher K; Cook D; Avery RK
Transpl Infect Dis; 2000 Sep; 2(3):133-9. PubMed ID: 11429024
[TBL] [Abstract][Full Text] [Related]
20. Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes.
Doron S; Ruthazer R; Werner BG; Rabson A; Snydman DR
Transplantation; 2006 Mar; 81(5):697-703. PubMed ID: 16534471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
